Loading…

Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment

Strontium ranelate (SrR) is a relatively new treatment for osteoporosis. In this study we investigated its potential impact on human bone material quality in transiliac bone biopsies from postmenopausal osteoporotic women treated 3 years with calcium and vitamin D plus either 2 g SrR per day or plac...

Full description

Saved in:
Bibliographic Details
Published in:Journal of bone and mineral research 2010-04, Vol.25 (4), p.891-900
Main Authors: Roschger, Paul, Manjubala, Inderchand, Zoeger, Norbert, Meirer, Florian, Simon, Rolf, Li, Chenghao, Fratzl‐Zelman, Nadja, Misof, Barbara M, Paschalis, Eleftherios P, Streli, Christina, Fratzl, Peter, Klaushofer, Klaus
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Strontium ranelate (SrR) is a relatively new treatment for osteoporosis. In this study we investigated its potential impact on human bone material quality in transiliac bone biopsies from postmenopausal osteoporotic women treated 3 years with calcium and vitamin D plus either 2 g SrR per day or placebo. Bone mineralization density distribution (BMDD), strontium (Sr) concentration, collagen cross‐link ratio, and indentation modulus were analyzed by quantitative backscattered electron imaging, electron‐induced X‐ray fluorescence analysis, synchrotron radiation induced micro X‐ray fluorescence elemental mapping, Fourier transform infrared imaging, and nanoindentation, respectively. The BMDD of SrR‐treated patients was shifted to higher atomic numbers (Zmean +1.5%, p 
ISSN:0884-0431
1523-4681
DOI:10.1359/jbmr.091028